{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:57:21Z","timestamp":1794315441161,"version":"4.9.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10067-023-06504-z","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T05:05:56Z","timestamp":1673240756000},"page":"2717-2732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cardiovascular manifestations of monogenic periodic fever syndromes"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9186-3068","authenticated-orcid":false,"given":"Hafize Emine","family":"S\u00f6nmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5274-3285","authenticated-orcid":false,"given":"Ya\u011fmur","family":"Bay\u0131nd\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-2363","authenticated-orcid":false,"given":"Ezgi Deniz","family":"Batu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"6504_CR1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","volume":"78","author":"M Gattorno","year":"2019","unstructured":"Gattorno M, Hofer M, Federici S et al (2019) Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis 78:1025\u20131032","journal-title":"Ann Rheum Dis"},{"key":"6504_CR2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11926-022-01073-7","volume":"24","author":"ED Batu","year":"2022","unstructured":"Batu ED, Basaran O, Bilginer Y, Ozen S (2022) Familial Mediterranean fever: how to interpret genetic results? How to treat? A quarter of a century after the association with the Mefv gene. Curr Rheumatol Rep 24:206\u2013212","journal-title":"Curr Rheumatol Rep"},{"key":"6504_CR3","first-page":"13","volume":"9","author":"HE Sonmez","year":"2016","unstructured":"Sonmez HE, Batu ED, Ozen S (2016) Familial Mediterranean fever: current perspectives. J Inflamm Res 9:13\u201320","journal-title":"J Inflamm Res"},{"key":"6504_CR4","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417","journal-title":"Rheumatol Int"},{"key":"6504_CR5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41590-020-0705-6","volume":"21","author":"YH Park","year":"2020","unstructured":"Park YH, Remmers EF, Lee W et al (2020) Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis. Nat Immunol 21:857\u2013867","journal-title":"Nat Immunol"},{"key":"6504_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10067-016-3421-8","volume":"36","author":"HE Sonmez","year":"2017","unstructured":"Sonmez HE, Batu ED, Bilginer Y, Ozen S (2017) Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants. Clin Rheumatol 36:421\u2013425","journal-title":"Clin Rheumatol"},{"key":"6504_CR7","first-page":"1567","volume":"40","author":"F Kharouf","year":"2022","unstructured":"Kharouf F, Tsemach-Toren T, Ben-Chetrit E (2022) IL-1 inhibition in familial Mediterranean fever: clinical outcomes and expectations. Clin Exp Rheumatol 40:1567\u20131574","journal-title":"Clin Exp Rheumatol"},{"key":"6504_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00281-015-0484-6","volume":"37","author":"S Ozen","year":"2015","unstructured":"Ozen S, Batu ED (2015) The myths we believed in familial Mediterranean fever: what have we learned in the past years? Semin Immunopathol 37:363\u2013369","journal-title":"Semin Immunopathol"},{"key":"6504_CR9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00296-017-3853-8","volume":"38","author":"E Erken","year":"2018","unstructured":"Erken E, Erken E (2018) Cardiac disease in familial Mediterranean fever. Rheumatol Int 38:51\u201358","journal-title":"Rheumatol Int"},{"key":"6504_CR10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/qjmed\/90.10.643","volume":"90","author":"S Kees","year":"1997","unstructured":"Kees S, Langevitz P, Zemer D, Padeh S, Pras M, Livneh A (1997) Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). QJM 90:643\u2013647","journal-title":"QJM"},{"key":"6504_CR11","unstructured":"Okutur K, Seber S, Oztekin E, Bes C, Borlu F (2008) Recurrent pericarditis as the initial manifestation of familial Mediterranean fever. Med Sci Monit 14:CS139-141"},{"key":"6504_CR12","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/PEC.0000000000001251","volume":"33","author":"T Yoldas","year":"2017","unstructured":"Yoldas T, Kayali S, Ertugrul I, Dogan V, Orun UA, Karademir S (2017) Massive pericardial effusion and tamponade can be a first sign of familial Mediterranean fever. Pediatr Emerg Care 33:e48\u2013e51","journal-title":"Pediatr Emerg Care"},{"key":"6504_CR13","first-page":"67","volume":"12","author":"S Zimand","year":"1994","unstructured":"Zimand S, Tauber T, Hegesch T, Aladjem M (1994) Familial Mediterranean fever presenting with massive cardiac tamponade. Clin Exp Rheumatol 12:67\u201369","journal-title":"Clin Exp Rheumatol"},{"key":"6504_CR14","first-page":"8334375","volume":"2022","author":"A Malek","year":"2022","unstructured":"Malek A, Zeraati T, Sadr-Nabavi A, Vakili N, Abbaszadegan MR (2022) Cardiac tamponade: a rare manifestation of familial Mediterranean fever. Case Rep Rheumatol 2022:8334375","journal-title":"Case Rep Rheumatol"},{"key":"6504_CR15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000516182","volume":"8","author":"J Malik","year":"2021","unstructured":"Malik J, Shabbir A, Nazir A (2021) Cardiovascular sequelae and genetics of familial Mediterranean fever: a literature review. Pulse (Basel) 8:78\u201385","journal-title":"Pulse (Basel)"},{"key":"6504_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000152370.84628.0c","volume":"84","author":"Turkish FMF Study Group","year":"2005","unstructured":"Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1\u201311","journal-title":"Medicine (Baltimore)"},{"key":"6504_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12969-015-0057-1","volume":"13","author":"A Kilic","year":"2015","unstructured":"Kilic A, Varkal MA, Durmus MS, Yildiz I, Yildirim ZN, Turunc G et al (2015) Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever. Pediatr Rheumatol Online J 13:59","journal-title":"Pediatr Rheumatol Online J"},{"key":"6504_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1546-0096-12-5","volume":"12","author":"S Salah","year":"2014","unstructured":"Salah S, Hegazy R, Ammar R, Sheba H, Abdelrahman L (2014) MEFV gene mutations and cardiac phenotype in children with familial Mediterranean fever: a cohort study. Pediatr Rheumatol Online J 12:5","journal-title":"Pediatr Rheumatol Online J"},{"key":"6504_CR19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/heart.89.10.1257","volume":"89","author":"E Tutar","year":"2003","unstructured":"Tutar E, Yalcinkaya F, Ozkaya N, Ekim M, Atalay S (2003) Incidence of pericardial effusion during attacks of familial Mediterranean fever. Heart 89:1257\u20131258","journal-title":"Heart"},{"key":"6504_CR20","volume":"9","author":"K Ozturk","year":"2021","unstructured":"Ozturk K, Coskuner T, Baglan E et al (2021) Real-life data from the largest pediatric familial mediterranean fever cohort. Front Pediatr 9:805919","journal-title":"Front Pediatr"},{"key":"6504_CR21","first-page":"323","volume":"24","author":"H Ozdogan","year":"1997","unstructured":"Ozdogan H, Arisoy N, Kasapcapur O et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323\u2013327","journal-title":"J Rheumatol"},{"key":"6504_CR22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3389\/fimmu.2019.00763","volume":"10","author":"S Abbara","year":"2019","unstructured":"Abbara S, Grateau G, Ducharme-Benard S, Saadoun D, Georgin-Lavialle S (2019) Association of vasculitis and familial Mediterranean fever. Front Immunol 10:763","journal-title":"Front Immunol"},{"key":"6504_CR23","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s10067-019-04460-1","volume":"38","author":"SG Karadag","year":"2019","unstructured":"Karadag SG, Tanatar A, Sonmez HE, Cakmak F, Kiyak A, Yavuz S, Cakan M, Ayaz NA (2019) The clinical spectrum of Henoch-Schonlein purpura in children: a single-center study. Clin Rheumatol 38:1707\u20131714","journal-title":"Clin Rheumatol"},{"key":"6504_CR24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.27240","volume":"62","author":"C Pagnoux","year":"2010","unstructured":"Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L, French Vasculitis Study G (2010) Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62:616\u2013626","journal-title":"Arthritis Rheum"},{"key":"6504_CR25","first-page":"530","volume":"29","author":"E Ben-Chetrit","year":"2002","unstructured":"Ben-Chetrit E, Cohen R, Chajek-Shaul T (2002) Familial Mediterranean fever and Behcet's disease--are they associated? J Rheumatol 29:530\u2013534","journal-title":"J Rheumatol"},{"key":"6504_CR26","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.1073\/pnas.1306352110","volume":"110","author":"Y Kirino","year":"2013","unstructured":"Kirino Y, Zhou Q, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E et al (2013) Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease. Proc Natl Acad Sci U S A 110:8134\u20138139","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6504_CR27","doi-asserted-by":"crossref","unstructured":"Ilyas I, Little PJ, Liu Z, Xu Y, Kamato D, Berk BC, Weng J, Xu S (2022) Mouse models of atherosclerosis in translational research. Trends Pharmacol Sci","DOI":"10.1016\/j.tips.2022.06.009"},{"key":"6504_CR28","first-page":"39","volume":"3","author":"N Keles","year":"2016","unstructured":"Keles N, Aksu F, Aciksari G, Yilmaz Y, Demircioglu K, Kostek O, Cekin ME, Kalcik M, Caliskan M (2016) Is triglyceride\/HDL ratio a reliable screening test for assessment of atherosclerotic risk in patients with chronic inflammatory disease? North Clin Istanb 3:39\u201345","journal-title":"North Clin Istanb"},{"key":"6504_CR29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0003319716659220","volume":"68","author":"A Icli","year":"2017","unstructured":"Icli A, Cure E, Uslu AU, Sakiz D et al (2017) The relationship between atherogenic index and carotid artery atherosclerosis in familial Mediterranean fever. Angiology 68:315\u2013321","journal-title":"Angiology"},{"key":"6504_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.medici.2014.11.009","volume":"50","author":"A Acay","year":"2014","unstructured":"Acay A, Ulu MS, Ahsen A, Ozkececi G, Demir K, Ozuguz U, Yuksel S, Acarturk G (2014) Atherogenic index as a predictor of atherosclerosis in subjects with familial Mediterranean fever. Medicina (Kaunas) 50:329\u2013333","journal-title":"Medicina (Kaunas)"},{"key":"6504_CR31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13052-015-0120-z","volume":"41","author":"U Uluca","year":"2015","unstructured":"Uluca U, Demir F, Ece A, Sen V, Gunes A, Aktar F, Tan I, Karabel D, Yazgan U, Sabaz MN (2015) Assessment of epicardial adipose tissue thickness and the mean platelet volume in children with familial Mediterranean fever. Ital J Pediatr 41:15","journal-title":"Ital J Pediatr"},{"key":"6504_CR32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/1354750X.2018.1460764","volume":"23","author":"S Yel","year":"2018","unstructured":"Yel S, Dursun I, Cetin F, Bastug F, Tulpar S, Dusunsel R, Gunduz Z, Poyrazoglu H, Yilmaz K (2018) Increased circulating endothelial microparticles in children with FMF. Biomarkers 23:558\u2013562","journal-title":"Biomarkers"},{"key":"6504_CR33","first-page":"2024","volume":"35","author":"HM Terekeci","year":"2008","unstructured":"Terekeci HM, Oktenli C, Ozgurtas T, Nalbant S, Top C, Celik S et al (2008) Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? J Rheumatol 35:2024\u20132029","journal-title":"J Rheumatol"},{"key":"6504_CR34","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s10067-016-3532-2","volume":"36","author":"V Ozalper","year":"2017","unstructured":"Ozalper V, Kara M, Tanoglu A, Cetindagli I, Ozturker C, Hancerli Y, Hira S, Kara K, Beyazit Y, Yazgan Y (2017) Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation. Clin Rheumatol 36:2071\u20132077","journal-title":"Clin Rheumatol"},{"key":"6504_CR35","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.jacc.2006.09.013","volume":"48","author":"A Akdogan","year":"2006","unstructured":"Akdogan A, Calguneri M, Yavuz B et al (2006) Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 48:2351\u20132353","journal-title":"J Am Coll Cardiol"},{"key":"6504_CR36","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00296-008-0605-9","volume":"28","author":"Y Bilginer","year":"2008","unstructured":"Bilginer Y, Ozaltin F, Basaran C, Duzova A, Besbas N, Topaloglu R, Ozen S, Bakkaloglu A (2008) Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int 28:1211\u20131216","journal-title":"Rheumatol Int"},{"key":"6504_CR37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10067-007-0764-1","volume":"27","author":"H Peru","year":"2008","unstructured":"Peru H, Altun B, Dogan M, Kara F, Elmaci AM, Oran B (2008) The evaluation of carotid intima-media thickness in children with familial Mediterranean fever. Clin Rheumatol 27:689\u2013694","journal-title":"Clin Rheumatol"},{"key":"6504_CR38","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10067-006-0529-2","volume":"26","author":"I Sari","year":"2007","unstructured":"Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M, Akkoc N, Tunca M, Goktay Y, Onen F (2007) Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26:1467\u20131473","journal-title":"Clin Rheumatol"},{"key":"6504_CR39","doi-asserted-by":"crossref","first-page":"204800401882385","DOI":"10.1177\/2048004018823856","volume":"8","author":"M Kozan","year":"2019","unstructured":"Kozan M, Ozan ZT, Demir V, Ede H (2019) The relation of novel cardiovascular risk parameters in patients with familial Mediterranean fever. JRSM Cardiovasc Dis 8:2048004018823856","journal-title":"JRSM Cardiovasc Dis"},{"key":"6504_CR40","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0828-282X(06)70949-7","volume":"22","author":"M Yildiz","year":"2006","unstructured":"Yildiz M, Masatlioglu S, Seymen P, Aytac E, Sahin B, Seymen HO (2006) The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever. Can J Cardiol 22:1127\u20131131","journal-title":"Can J Cardiol"},{"key":"6504_CR41","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.693","volume":"5","author":"KR Motawea","year":"2022","unstructured":"Motawea KR, Kandil OA, Varney J, Aboelenein M, Ibrahim N, Shaheen A et al (2022) Association of familial Mediterranean fever and epicardial adipose tissue: a systematic review and meta-analysis. Health Sci Rep 5:e693","journal-title":"Health Sci Rep"},{"key":"6504_CR42","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/1756-185X.12356","volume":"20","author":"N Basar","year":"2017","unstructured":"Basar N, Kisacik B, Ercan S, Pehlivan Y, Yilmaz S, Simsek I et al (2017) Familial Mediterranean fever gene mutations as a risk factor for early coronary artery disease. Int J Rheum Dis 20:2113\u20132117","journal-title":"Int J Rheum Dis"},{"key":"6504_CR43","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.atherosclerosis.2007.06.014","volume":"195","author":"M Caliskan","year":"2007","unstructured":"Caliskan M, Gullu H, Yilmaz S, Erdogan D, Unler GK, Ciftci O, Topcu S, Kayhan Z, Yucel E, Muderrisoglu H (2007) Impaired coronary microvascular function in familial Mediterranean fever. Atherosclerosis 195:e161\u2013e167","journal-title":"Atherosclerosis"},{"key":"6504_CR44","unstructured":"Ambartsymian SV (2012) Myocardial infarction in patients with familial Mediterranean fever and cardiac lesions. Georgian Med News 62-66"},{"key":"6504_CR45","first-page":"272","volume":"6","author":"H Uyarel","year":"2006","unstructured":"Uyarel H, Karabulut A, Okmen E, Cam N (2006) Familial Mediterranean fever and acute anterior myocardial infarction in a young patient. Anadolu Kardiyol Derg 6:272\u2013274","journal-title":"Anadolu Kardiyol Derg"},{"key":"6504_CR46","first-page":"9","volume":"3","author":"P Langevitz","year":"2001","unstructured":"Langevitz P, Livneh A, Neumann L, Buskila D, Shemer J, Amolsky D, Pras M (2001) Prevalence of ischemic heart disease in patients with familial Mediterranean fever. Isr Med Assoc J 3:9\u201312","journal-title":"Isr Med Assoc J"},{"key":"6504_CR47","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13473","volume":"74","author":"O Gendelman","year":"2020","unstructured":"Gendelman O, Shapira R, Tiosano S, Pras E, Comaneshter D, Cohen A, Amital H (2020) Familial Mediterranean fever is associated with increased risk for ischaemic heart disease and mortality-perspective derived from a large database. Int J Clin Pract 74:e13473","journal-title":"Int J Clin Pract"},{"key":"6504_CR48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12975-019-00706-x","volume":"11","author":"S Rupprecht","year":"2020","unstructured":"Rupprecht S, Finn S, Hoyer D, Guenther A, Witte OW, Schultze T, Schwab M (2020) Association between systemic inflammation, carotid arteriosclerosis, and autonomic dysfunction. Transl Stroke Res 11:50\u201359","journal-title":"Transl Stroke Res"},{"key":"6504_CR49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00296-003-0344-x","volume":"24","author":"M Rozenbaum","year":"2004","unstructured":"Rozenbaum M, Naschitz JE, Yudashkin M, Sabo E, Shaviv N, Gaitini L, Zuckerman E, Yeshurun D, Rosner I (2004) Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever. Rheumatol Int 24:147\u2013152","journal-title":"Rheumatol Int"},{"key":"6504_CR50","first-page":"987","volume":"29","author":"M Rozenbaum","year":"2002","unstructured":"Rozenbaum M, Naschitz JE, Yudashkin M, Rosner I, Sabo E, Shaviv N, Gaitini L, Zuckerman E, Yeshurun D (2002) Cardiovascular autonomic dysfunction in familial Mediterranean fever. J Rheumatol 29:987\u2013989","journal-title":"J Rheumatol"},{"key":"6504_CR51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.autneu.2011.11.001","volume":"167","author":"U Canpolat","year":"2012","unstructured":"Canpolat U, Dural M, Aytemir K et al (2012) Evaluation of various cardiac autonomic indices in patients with familial Mediterranean fever on colchicine treatment. Auton Neurosci 167:70\u201374","journal-title":"Auton Neurosci"},{"key":"6504_CR52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00296-010-1550-y","volume":"31","author":"I Ardic","year":"2011","unstructured":"Ardic I, Kaya MG, Yarlioglues M, Dogdu O, Celikbilek M, Akpek M, Akyol L, Torun E (2011) Assessment of heart rate recovery index in patients with familial Mediterranean fever. Rheumatol Int 31:121\u2013125","journal-title":"Rheumatol Int"},{"key":"6504_CR53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5606\/ArchRheumatol.2017.6071","volume":"32","author":"H Evrengul","year":"2017","unstructured":"Evrengul H, Yuksel S, Dogan M, Gurses D, Evrengul H (2017) Deteriorated systolic blood pressure recovery and heart rate recovery after graded exercise in children with familial Mediterranean fever. Arch Rheumatol 32:244\u2013249","journal-title":"Arch Rheumatol"},{"key":"6504_CR54","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s10067-014-2714-z","volume":"35","author":"M Sahin","year":"2016","unstructured":"Sahin M, Kir M, Makay B, Keskinoglu P, Bora E, Unsal E, Unal N (2016) Cardiac autonomic functions in children with familial Mediterranean fever. Clin Rheumatol 35:1237\u20131244","journal-title":"Clin Rheumatol"},{"key":"6504_CR55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00296-009-1214-y","volume":"31","author":"N Nussinovitch","year":"2011","unstructured":"Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2011) Heart rate variability in familial Mediterranean fever. Rheumatol Int 31:39\u201343","journal-title":"Rheumatol Int"},{"key":"6504_CR56","unstructured":"Nussinovitch N, Esev K, Lidar M, Nussinovitch U, Livneh A (2015) Normal Heart rate variability in colchicine-resistant familial Mediterranean fever patients. The I Isr Med Assoc J 17:306-309."},{"key":"6504_CR57","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/13506129.2011.616556","volume":"18","author":"U Nussinovitch","year":"2011","unstructured":"Nussinovitch U, Volovitz B, Nussinovitch M, Lidar M, Feld O, Nussinovitch N, Livneh A (2011) Abnormal heart rate variability in AA amyloidosis of familial Mediterranean fever. Amyloid 18:206\u2013210","journal-title":"Amyloid"},{"key":"6504_CR58","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10067-011-1926-8","volume":"31","author":"U Nussinovitch","year":"2012","unstructured":"Nussinovitch U, Kaminer K, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch N, Livneh A (2012) QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients. Clin Rheumatol 31:795\u2013799","journal-title":"Clin Rheumatol"},{"key":"6504_CR59","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10067-012-1982-8","volume":"31","author":"U Nussinovitch","year":"2012","unstructured":"Nussinovitch U, Livneh A, Volovitz B, Nussinovitch M, Ben-Zvi I, Lidar M, Nussinovitch N (2012) Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF). Clin Rheumatol 31:1093\u20131096","journal-title":"Clin Rheumatol"},{"key":"6504_CR60","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.7150\/ijms.9444","volume":"11","author":"A Giese","year":"2014","unstructured":"Giese A, Ornek A, Kurucay M, Kara K, Wittkowski H, Gohar F, Menge BA, Schmidt WE, Zeidler C (2014) P wave dispersion and QT dispersion in adult Turkish migrants with familial Mediterranean fever living in Germany. Int J Med Sci 11:1140\u20131146","journal-title":"Int J Med Sci"},{"key":"6504_CR61","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4067\/S0034-98872015001200009","volume":"143","author":"E Ahbap","year":"2015","unstructured":"Ahbap E, Sakaci T, Kara E, Sahutoglu T, Ozturk S, Basturk T et al (2015) Familial Mediterranean fever is associated with abnormal ventricular repolarization indices. Rev Med Chil 143:1560\u20131568","journal-title":"Rev Med Chil"},{"key":"6504_CR62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12969-022-00696-5","volume":"20","author":"Y Farag","year":"2022","unstructured":"Farag Y, Sayed S, Mostafa FA, Marzouk H, Mohamed RH, Sobhy R (2022) Cardiac repolarization abnormalities in children with familial Mediterranean fever. Pediatr Rheumatol Online J 20:38","journal-title":"Pediatr Rheumatol Online J"},{"key":"6504_CR63","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00431-010-1158-y","volume":"169","author":"V Akse-Onal","year":"2010","unstructured":"Akse-Onal V, Sag E, Ozen S, Bakkaloglu A, Cakar N, Besbas N, Gucer S (2010) Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better? Eur J Pediatr 169:971\u2013974","journal-title":"Eur J Pediatr"},{"key":"6504_CR64","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/rheumatology\/keu231","volume":"53","author":"MI Yilmaz","year":"2014","unstructured":"Yilmaz MI, Demirkaya E, Acikel C et al (2014) Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events. Rheumatology (Oxford) 53:2002\u20132008","journal-title":"Rheumatology (Oxford)"},{"key":"6504_CR65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11255-020-02652-2","volume":"53","author":"I Bozaci","year":"2021","unstructured":"Bozaci I, Tatar E (2021) The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors. Int Urol Nephrol 53:531\u2013538","journal-title":"Int Urol Nephrol"},{"key":"6504_CR66","doi-asserted-by":"crossref","unstructured":"Sahin S, Romano M, Guzel F, Piskin D, Poddighe D, Sezer S, Kasapcopur O, Appleton CT, Yilmaz I, Demirkaya E (2022) Assessment of surrogate markers for cardiovascular disease in familial Mediterranean fever-related amyloidosis patients homozygous for M694V mutation in MEFV gene. Life (Basel) 12(5)","DOI":"10.3390\/life12050631"},{"key":"6504_CR67","doi-asserted-by":"crossref","first-page":"663","DOI":"10.5152\/akd.2014.5544","volume":"15","author":"O Ceylan","year":"2015","unstructured":"Ceylan O, Ozgur S, Orun UA, Dogan V, Yilmaz O, Keskin M, Ari ME, Erdogan O, Karademir S (2015) Assessment of left ventricular functions with tissue Doppler, strain, and strain rate echocardiography in patients with familial Mediterranean fever. Anatol J Cardiol 15:663\u2013668","journal-title":"Anatol J Cardiol"},{"key":"6504_CR68","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5606\/ArchRheumatol.2019.7005","volume":"34","author":"H Erken Pamukcu","year":"2019","unstructured":"Erken Pamukcu H, Dogan M, Ozisler C, Sunman H, Pamukcu M, Dinc Asarcikli L (2019) Effects of familial Mediterranean fever on cardiac functions in adults: a cross-sectional study based on speckle tracking echocardiography. Arch Rheumatol 34:204\u2013210","journal-title":"Arch Rheumatol"},{"key":"6504_CR69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00508-015-0714-x","volume":"127","author":"MM Celik","year":"2015","unstructured":"Celik MM, Buyukkaya E, Ustun N, Nacar AB, Kurt M, Karakas MF, Bilen P, Duru M, Sen N, Akcay AB (2015) Relation of fragmented QRS to tissue Doppler-derived parametersin patients with familial Mediterranean fever. Wien Klin Wochenschr 127:185\u2013190","journal-title":"Wien Klin Wochenschr"},{"key":"6504_CR70","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2217\/fca-2020-0206","volume":"18","author":"M Casula","year":"2022","unstructured":"Casula M, Andreis A, Avondo S, Vaira MP, Imazio M (2022) Colchicine for cardiovascular medicine: a systematic review and meta-analysis. Futur Cardiol 18:647\u2013659","journal-title":"Futur Cardiol"},{"key":"6504_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40256-020-00408-y","volume":"21","author":"TF Whayne","year":"2021","unstructured":"Whayne TF (2021) Inflammation may be the future of cardiovascular risk reduction: does colchicine have a current indication? Am J Cardiovasc Drugs 21:1\u201310","journal-title":"Am J Cardiovasc Drugs"},{"key":"6504_CR72","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD et al (2019) Efficacy and Safety of low-dose colchicine after myocardial infarction. N Engl J Med 381:2497\u20132505","journal-title":"N Engl J Med"},{"key":"6504_CR73","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bcpt.12702","volume":"120","author":"G Frommeyer","year":"2017","unstructured":"Frommeyer G, Krawczyk J, Dechering DG, Kochhauser S, Leitz P, Fehr M, Eckardt L (2017) Colchicine increases ventricular vulnerability in an experimental whole-heart model. Basic Clin Pharmacol Toxicol 120:505\u2013508","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"6504_CR74","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00393-019-0642-7","volume":"79","author":"AG Ocal","year":"2020","unstructured":"Ocal AG, Ocal L, Kup A, Eren H, Tezcan ME (2020) Colchicine's effects on electrocardiographic parameters in newly diagnosed familial Mediterranean fever patients: colchicine may have favourable effects on parameters related to ventricular arrhythmias in new diagnosed familial Mediterranean fever. Z Rheumatol 79:210\u2013215","journal-title":"Z Rheumatol"},{"key":"6504_CR75","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/RHU.0000000000001465","volume":"26","author":"U Nussinovitch","year":"2020","unstructured":"Nussinovitch U, Stahi T, Livneh A (2020) Evaluation of a proarrhythmic repolarization marker (total cosine R to T) in patients with uncomplicated familial Mediterranean fever. J Clin Rheumatol 26:334\u2013337","journal-title":"J Clin Rheumatol"},{"key":"6504_CR76","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/annrheumdis-2019-216040","volume":"78","author":"VE Saper","year":"2019","unstructured":"Saper VE, Chen G, Deutsch GH et al (2019) Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis 78:1722\u20131731","journal-title":"Ann Rheum Dis"},{"key":"6504_CR77","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2021-220578","volume":"81","author":"VE Saper","year":"2022","unstructured":"Saper VE, Ombrello MJ, Tremoulet AH et al (2022) Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles. Ann Rheum Dis 81:406\u2013415","journal-title":"Ann Rheum Dis"},{"key":"6504_CR78","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1542\/peds.2012-1372","volume":"133","author":"VS Thors","year":"2014","unstructured":"Thors VS, Vastert SJ, Wulffraat N, van Royen A, Frenkel J, de Sain-van der Velden M, de Koning TJ (2014) Periodic fever in MVK deficiency: a patient initially diagnosed with incomplete Kawasaki disease. Pediatrics 133:e461\u2013e465","journal-title":"Pediatrics"},{"issue":"3","key":"6504_CR79","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clim.2012.09.011","volume":"147","author":"R van der Burgh","year":"2013","unstructured":"van der Burgh R, Ter Haar NM, Boes ML, Frenkel J (2013) Mevalonate kinase deficiency, a metabolic autoinflammatory disease. Clin Immunol 147(3):197\u2013206","journal-title":"Clin Immunol"},{"key":"6504_CR80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/8904_2015_489","volume":"27","author":"J Jeyaratnam","year":"2016","unstructured":"Jeyaratnam J, Ter Haar NM, de Sain-van der Velden MG, Waterham HR, van Gijn ME, Frenkel J (2016) Diagnostic value of urinary mevalonic acid excretion in patients with a clinical suspicion of mevalonate kinase deficiency (MKD). JIMD Rep 27:33\u201338","journal-title":"JIMD Rep"},{"key":"6504_CR81","first-page":"695","volume":"27","author":"L Breda","year":"2009","unstructured":"Breda L, Nozzi M, Di Marzio D, De Sanctis S, Gattorno M, Chiarelli F (2009) Recurrent pericarditis in hyper-IgD syndrome. Clin Exp Rheumatol 27:695","journal-title":"Clin Exp Rheumatol"},{"key":"6504_CR82","doi-asserted-by":"crossref","first-page":"e024931","DOI":"10.1161\/JAHA.121.024931","volume":"11","author":"CJ Peet","year":"2022","unstructured":"Peet CJ, Rowczenio D, Omoyinmi E, Papadopoulou C, BRR M, Wood MR, Capon F, Lachmann HJ (2022) Pericarditis and autoinflammation: a clinical and genetic analysis of patients with idiopathic recurrent pericarditis and monogenic autoinflammatory diseases at a national referral center. J Am Heart Assoc 11:e024931","journal-title":"J Am Heart Assoc"},{"key":"6504_CR83","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","volume":"40","author":"CJ Willer","year":"2008","unstructured":"Willer CJ, Sanna S, Jackson AU et al (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40:161\u2013169","journal-title":"Nat Genet"},{"key":"6504_CR84","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer CJ, Schmidt EM, Sengupta S et al (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45:1274\u20131283","journal-title":"Nat Genet"},{"key":"6504_CR85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12944-016-0348-7","volume":"15","author":"J Sun","year":"2016","unstructured":"Sun J, Qian Y, Jiang Y et al (2016) Association of KCTD10, MVK, and MMAB polymorphisms with dyslipidemia and coronary heart disease in Han Chinese population. Lipids Health Dis 15:171","journal-title":"Lipids Health Dis"},{"key":"6504_CR86","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/annrheumdis-2021-221801","volume":"81","author":"M Romano","year":"2022","unstructured":"Romano M, Arici ZS, Piskin D et al (2022) The 2021 EULAR\/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Ann Rheum Dis 81:907\u2013921","journal-title":"Ann Rheum Dis"},{"key":"6504_CR87","doi-asserted-by":"crossref","unstructured":"Welzel T, Kuemmerle-Deschner JB (2021) Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today? J Clin Med 10","DOI":"10.3390\/jcm10010128"},{"key":"6504_CR88","first-page":"1","volume":"13","author":"JB Kuemmerle-Deschner","year":"2011","unstructured":"Kuemmerle-Deschner JB, Lohse P, Koetter I, Dannecker GE, Reess F, Ummenhofer K, Koch S, Tzaribachev N, Bialkowski A, Benseler SM (2011) NLRP3 E311K mutation in a large family with Muckle-Wells syndrome-description of a heterogeneous phenotype and response to treatment. Arthritis Res Ther 13:1\u20139","journal-title":"Arthritis Res Ther"},{"key":"6504_CR89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00296-017-3854-7","volume":"38","author":"R Hintenberger","year":"2018","unstructured":"Hintenberger R, Falkinger A, Danninger K, Pieringer H (2018) Cardiovascular disease in patients with autoinflammatory syndromes. Rheumatol Int 38:37\u201350","journal-title":"Rheumatol Int"},{"key":"6504_CR90","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s11427-017-9246-4","volume":"60","author":"C Li","year":"2017","unstructured":"Li C, Tan X, Zhang J, Li S, Mo W, Han T, Kuang W, Zhou Y, Deng J (2017) Gene mutations and clinical phenotypes in 15 Chinese children with cryopyrin-associated periodic syndrome (CAPS). Sci China Life Sci 60:1436\u20131444","journal-title":"Sci China Life Sci"},{"key":"6504_CR91","doi-asserted-by":"crossref","unstructured":"Endo K, Suzuki A, Sato K, Shiga T (2015) Sudden cardiac arrest secondary to cardiac amyloidosis in a young woman with cryopyrin-associated periodic syndrome. BMJ Case Rep 2015","DOI":"10.1136\/bcr-2015-209468"},{"key":"6504_CR92","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/rheumatology\/keu180","volume":"53","author":"K Yamamura","year":"2014","unstructured":"Yamamura K, Takada H, Uike K, Nakashima Y, Hirata Y, Nagata H et al (2014) Early progression of atherosclerosis in children with chronic infantile neurological cutaneous and articular syndrome. Rheumatology (Oxford) 53:1783\u20131787","journal-title":"Rheumatology (Oxford)"},{"key":"6504_CR93","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/07853890.2010.547212","volume":"43","author":"D Rigante","year":"2011","unstructured":"Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M, Brizi MG, Brucato A (2011) Autoinflammatory diseases and cardiovascular manifestations. Ann Med 43:341\u2013346","journal-title":"Ann Med"},{"key":"6504_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405009749","volume":"7","author":"S Stojanov","year":"2005","unstructured":"Stojanov S, McDermott MF (2005) The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med 7:1\u201318","journal-title":"Expert Rev Mol Med"},{"key":"6504_CR95","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/039463200902200421","volume":"22","author":"L Cantarini","year":"2009","unstructured":"Cantarini L, Lucherini O, Cimaz R, Baldari C, Bellisai F, Paccani SR, Pasini FL, Capecchi P, Sebastiani G, Galeazzi M (2009) Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol 22:1051\u20131058","journal-title":"Int J Immunopathol Pharmacol"},{"key":"6504_CR96","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00392-012-0422-8","volume":"101","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Lucherini OM, Brucato A et al (2012) Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol 101:525\u2013531","journal-title":"Clin Res Cardiol"},{"key":"6504_CR97","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/321976","volume":"69","author":"I Aksentijevich","year":"2001","unstructured":"Aksentijevich I, Galon J, Soares M et al (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69:301\u2013314","journal-title":"Am J Hum Genet"},{"key":"6504_CR98","first-page":"175","volume":"32","author":"S Trost","year":"2005","unstructured":"Trost S, Ros\u00e9 CD (2005) Myocarditis and sacroiliitis: 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome. J Rheumatol 32:175\u2013177","journal-title":"J Rheumatol"},{"key":"6504_CR99","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ejim.2008.07.028","volume":"20","author":"F Roubille","year":"2009","unstructured":"Roubille F, Cayla G, Gahide G, Mourad G, Macia JC (2009) Acute myocarditis and tumor necrosis factor receptor-associated periodic (TRAP) syndrome: first case described and discussion. Eur J Intern Med 20:e25\u2013e26","journal-title":"Eur J Intern Med"},{"key":"6504_CR100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ejhg.5201143","volume":"12","author":"O Poirier","year":"2004","unstructured":"Poirier O, Nicaud V, Gariepy J et al (2004) Polymorphism R92Q of the tumour necrosis factor receptor 1 gene is associated with myocardial infarction and carotid intima-media thickness--the ECTIM, AXA, EVA and GENIC studies. Eur J Hum Genet 12:213\u2013219","journal-title":"Eur J Hum Genet"},{"key":"6504_CR101","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2007.079376","volume":"67","author":"S Stojanov","year":"2008","unstructured":"Stojanov S, Dejaco C, Lohse P, Huss K, Duftner C, Belohradsky BH, Herold M, Schirmer M (2008) Clinical and functional characterisation of a novel TNFRSF1A c.605T>A\/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann Rheum Dis 67:1292\u20131298","journal-title":"Ann Rheum Dis"},{"key":"6504_CR102","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.20873","volume":"52","author":"Z Amoura","year":"2005","unstructured":"Amoura Z, Dode C, Hue S, Caillat-Zucman S, Bahram S, Delpech M, Grateau G, Wechsler B, Piette JC (2005) Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behcet's disease. Arthritis Rheum 52:608\u2013611","journal-title":"Arthritis Rheum"},{"key":"6504_CR103","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.ATV.0000065195.22904.FA","volume":"23","author":"S Chia","year":"2003","unstructured":"Chia S, Qadan M, Newton R, Ludlam CA, Fox KA, Newby DE (2003) Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol 23:695\u2013701","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06504-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06504-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06504-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T06:26:00Z","timestamp":1701671160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06504-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":103,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6504"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06504-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}